InsidersTradesSigma
Track the 한화생명 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Banks sector, 한화생명 has logged 5 insider filings. Market capitalisation: €3,328.7bn. The latest transaction was reported on 30 June 2026 (Purchase). Among the most active insiders: 이종호. The full history is free.
Analysts rate 한화생명 Hold (neutral), based on 13 analysts. Average price target: ₩5,200.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Hanwha Life es una compañía de seguros surcoreana que ofrece varios productos de seguros de vida y servicios financieros. Cotiza en la Bolsa de Corea, XKRX.